Whether you're managing type 2 diabetes or obesity, structured tracking supports evidence-based treatment decisions and shared decision-making with your healthcare provider, ensuring your GLP-1 therapy achieves therapeutic goals while minimizing risks
Not in replacing human judgment, but in restoring it by giving professionals better inputs to think with #Lean I also wonder how many organizations are sitting on similar hidden datasets, pages of Excel sheets filled with free text such as customer complaints, control gaps, or performance review notes
Here's a breakdown of the best times to take L carnitine: When to Take L Carnitine For Weight Management Taking L-carnitine in the morning, particularly in a fasted state, has been shown to accelerate weight management in some people
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention
Add-on to metformin with or without SGLT2 inhibitor SURPASS-3 (NCT03882970) was a 52-week open-label trial that randomized 1444 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin with or without SGLT2 inhibitor to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin degludec 100 units/mL once daily